Compumedics Ltd (CMP) - Net Assets

Latest as of June 2025: AU$21.82 Million AUD ≈ $15.44 Million USD

Based on the latest financial reports, Compumedics Ltd (CMP) has net assets worth AU$21.82 Million AUD (≈ $15.44 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$54.39 Million ≈ $38.48 Million USD) and total liabilities (AU$32.57 Million ≈ $23.04 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Compumedics Ltd to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AU$21.82 Million
% of Total Assets	40.12%
Annual Growth Rate	-1.27%
5-Year Change	-1.5%
10-Year Change	49.51%
Growth Volatility	23.23

Compumedics Ltd - Net Assets Trend (2000–2025)

This chart illustrates how Compumedics Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Compumedics Ltd balance sheet assets for the complete picture of this company's asset base.

Annual Net Assets for Compumedics Ltd (2000–2025)

The table below shows the annual net assets of Compumedics Ltd from 2000 to 2025. For live valuation and market cap data, see Compumedics Ltd market cap and net worth.

Year	Net Assets	Change
2025-06-30	AU$21.82 Million ≈ $15.44 Million	+19.84%
2024-06-30	AU$18.21 Million ≈ $12.88 Million	-0.44%
2023-06-30	AU$18.29 Million ≈ $12.94 Million	-22.47%
2022-06-30	AU$23.59 Million ≈ $16.69 Million	+6.48%
2021-06-30	AU$22.16 Million ≈ $15.68 Million	+1.66%
2020-06-30	AU$21.79 Million ≈ $15.42 Million	-20.22%
2019-06-30	AU$27.32 Million ≈ $19.33 Million	+17.95%
2018-06-30	AU$23.16 Million ≈ $16.39 Million	+15.51%
2017-06-30	AU$20.05 Million ≈ $14.19 Million	+37.37%
2016-06-30	AU$14.60 Million ≈ $10.33 Million	+29.53%
2015-06-30	AU$11.27 Million ≈ $7.97 Million	+22.99%
2014-06-30	AU$9.16 Million ≈ $6.48 Million	+9.69%
2013-06-30	AU$8.35 Million ≈ $5.91 Million	-9.35%
2012-06-30	AU$9.21 Million ≈ $6.52 Million	-27.75%
2011-06-30	AU$12.76 Million ≈ $9.02 Million	+4.58%
2010-06-30	AU$12.20 Million ≈ $8.63 Million	+6.25%
2009-06-30	AU$11.48 Million ≈ $8.12 Million	+34.94%
2008-06-30	AU$8.51 Million ≈ $6.02 Million	+23.04%
2007-06-30	AU$6.91 Million ≈ $4.89 Million	+2.93%
2006-06-30	AU$6.72 Million ≈ $4.75 Million	-28.14%
2005-06-30	AU$9.35 Million ≈ $6.61 Million	-32.97%
2004-06-30	AU$13.95 Million ≈ $9.87 Million	+19.44%
2003-06-30	AU$11.68 Million ≈ $8.26 Million	-61.37%
2002-06-30	AU$30.23 Million ≈ $21.39 Million	-6.02%
2001-06-30	AU$32.16 Million ≈ $22.76 Million	+6.97%
2000-06-30	AU$30.07 Million ≈ $21.27 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Compumedics Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 1932.7% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component	Amount	Percentage
Common Stock	AU$39.45 Million	180.76%
Other Comprehensive Income	AU$959.00K	4.39%
Other Components	AU$1.00	0.00%
Total Equity	AU$21.82 Million	100.00%

Compumedics Ltd Competitors by Market Cap

The table below lists competitors of Compumedics Ltd ranked by their market capitalization.

Company	Market Cap
Mtag Group Berhad KLSE:0213	$41.71 Million
AbL Diagnostics SA PA:ABLD	$41.73 Million
Kaya Limited NSE:KAYA	$41.74 Million
WebCash Corporation KQ:053580	$41.76 Million
Urban Jakarta Propertindo Tbk PT JK:URBN	$41.68 Million
R.P.P. Infra Projects Limited NSE:RPPINFRA	$41.66 Million
Koss Corporation NASDAQ:KOSS	$41.66 Million
TechPrecision Corporation Common stock NASDAQ:TPCS	$41.65 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Compumedics Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 18,210,000 to 21,823,000, a change of 3,613,000 (19.8%).
Net loss of 1,272,000 reduced equity.
Other comprehensive income increased equity by 1,090,999.
Other factors increased equity by 3,794,001.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	AU$-1.27 Million	-5.83%
Other Comprehensive Income	AU$1.09 Million	+5.0%
Other Changes	AU$3.79 Million	+17.39%
Total Change	AU$-	19.84%

Book Value vs Market Value Analysis

This analysis compares Compumedics Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.46x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has increased from 1.37x to 2.46x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2000-06-30	AU$0.21	AU$0.30	x
2001-06-30	AU$0.28	AU$0.30	x
2002-06-30	AU$0.22	AU$0.30	x
2003-06-30	AU$0.08	AU$0.30	x
2004-06-30	AU$0.10	AU$0.30	x
2005-06-30	AU$0.07	AU$0.30	x
2006-06-30	AU$0.05	AU$0.30	x
2007-06-30	AU$0.06	AU$0.30	x
2008-06-30	AU$0.06	AU$0.30	x
2009-06-30	AU$0.07	AU$0.30	x
2010-06-30	AU$0.08	AU$0.30	x
2011-06-30	AU$0.08	AU$0.30	x
2012-06-30	AU$0.06	AU$0.30	x
2013-06-30	AU$0.05	AU$0.30	x
2014-06-30	AU$0.05	AU$0.30	x
2015-06-30	AU$0.07	AU$0.30	x
2016-06-30	AU$0.09	AU$0.30	x
2017-06-30	AU$0.11	AU$0.30	x
2018-06-30	AU$0.13	AU$0.30	x
2019-06-30	AU$0.15	AU$0.30	x
2020-06-30	AU$0.12	AU$0.30	x
2021-06-30	AU$0.13	AU$0.30	x
2022-06-30	AU$0.13	AU$0.30	x
2023-06-30	AU$0.10	AU$0.30	x
2024-06-30	AU$0.10	AU$0.30	x
2025-06-30	AU$0.12	AU$0.30	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Compumedics Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -5.83%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -2.49%
• Asset Turnover: 0.94x
• Equity Multiplier: 2.49x
Recent ROE (-5.83%) is above the historical average (-7.40%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2000	-0.32%	-1.06%	0.26x	1.15x	AU$-3.10 Million
2001	6.13%	11.85%	0.42x	1.22x	AU$-1.25 Million
2002	-6.28%	-9.61%	0.45x	1.44x	AU$-4.92 Million
2003	-158.94%	-57.89%	1.35x	2.04x	AU$-19.72 Million
2004	17.19%	7.06%	1.39x	1.76x	AU$1.00 Million
2005	-41.70%	-10.12%	1.57x	2.63x	AU$-4.83 Million
2006	-23.75%	-4.10%	1.75x	3.30x	AU$-2.27 Million
2007	1.78%	0.33%	1.92x	2.78x	AU$-568.40K
2008	8.89%	1.96%	1.92x	2.37x	AU$-94.70K
2009	23.76%	7.14%	1.78x	1.87x	AU$1.58 Million
2010	3.39%	1.27%	1.50x	1.79x	AU$-805.60K
2011	0.64%	0.26%	1.35x	1.81x	AU$-1.19 Million
2012	-30.70%	-10.13%	1.40x	2.16x	AU$-3.75 Million
2013	-17.83%	-5.48%	1.42x	2.29x	AU$-2.32 Million
2014	9.92%	3.13%	1.49x	2.13x	AU$-7.20K
2015	17.48%	5.88%	1.55x	1.92x	AU$843.20K
2016	22.42%	8.72%	1.44x	1.79x	AU$1.81 Million
2017	6.51%	3.79%	1.18x	1.46x	AU$-700.10K
2018	12.02%	7.52%	1.07x	1.50x	AU$468.00K
2019	14.70%	9.68%	1.07x	1.42x	AU$1.28 Million
2020	-26.79%	-16.65%	0.99x	1.63x	AU$-8.02 Million
2021	4.50%	2.79%	0.93x	1.74x	AU$-1.22 Million
2022	5.75%	3.59%	0.91x	1.77x	AU$-1.00 Million
2023	-33.47%	-14.44%	1.03x	2.25x	AU$-7.95 Million
2024	-1.86%	-0.68%	1.23x	2.22x	AU$-2.16 Million
2025	-5.83%	-2.49%	0.94x	2.49x	AU$-3.45 Million

Industry Comparison

This section compares Compumedics Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $66,877,920
Average return on equity (ROE) among peers: -38.60%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Compumedics Ltd (CMP)	AU$21.82 Million	-0.32%	1.49x	$41.70 Million
4DMEDICAL Ltd (4DX)	$64.24 Million	-46.81%	0.48x	$1.63 Billion
Adherium Ltd (ADR)	$-4.76 Million	0.00%	0.00x	$7.37 Million
Aroa Biosurgery Ltd (ARX)	$6.92 Million	-23.35%	0.08x	$150.91 Million
Atomo Diagnostics Ltd (AT1)	$-5.47 Million	0.00%	0.00x	$13.76 Million
Avita Medical Inc (AVH)	$5.12 Million	-224.74%	0.50x	$132.15 Million
Anteris Technologies Global Corp (AVR)	$22.64 Million	-106.07%	0.18x	$570.83 Million
Control Bionics Ltd (CBL)	$5.05 Million	-38.22%	0.07x	$18.95 Million
Cardiex Ltd (CDX)	$4.88 Million	56.04%	0.31x	$13.23 Million
Cochlear Ltd (COH)	$503.28 Million	35.79%	0.47x	$4.60 Billion

About Compumedics Ltd

AU:CMP Australia Medical Devices

Market Cap

$41.70 Million

AU$58.93 Million AUD

Market Cap Rank

#22544 Global

#842 in Australia

Share Price

AU$0.30

Change (1 day)

+3.51%

52-Week Range

AU$0.25 - AU$0.45

All Time High

AU$0.90